Bioregenx (BRGX) Change in Receivables (2023 - 2025)
Bioregenx has reported Change in Receivables over the past 3 years, most recently at -$22892.0 for Q4 2025.
- For Q4 2025, Change in Receivables fell 414.43% year-over-year to -$22892.0; the TTM value through Dec 2025 reached $24726.0, up 127.6%, while the annual FY2025 figure was $24726.0, 127.6% up from the prior year.
- Change in Receivables for Q4 2025 was -$22892.0 at Bioregenx, down from $41495.0 in the prior quarter.
- Over five years, Change in Receivables peaked at $41495.0 in Q3 2025 and troughed at -$93406.0 in Q1 2024.
- A 3-year average of -$3643.4 and a median of $605.0 in 2023 define the central range for Change in Receivables.
- Biggest five-year swings in Change in Receivables: plummeted 482.15% in 2024 and later soared 4393.1% in 2025.
- Year by year, Change in Receivables stood at $22584.0 in 2023, then plummeted by 119.7% to -$4450.0 in 2024, then plummeted by 414.43% to -$22892.0 in 2025.
- Business Quant data shows Change in Receivables for BRGX at -$22892.0 in Q4 2025, $41495.0 in Q3 2025, and $9960.0 in Q2 2025.